Discontinued — last reported Q4 '25

Investing

Acquisitions

Over 2 years (FY 2021 to FY 2024), Acquisitions shows a downward trend with a -100.0% CAGR.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2013
Last reportedQ4 2025

How to read this metric

High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.

Detailed definition

This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...

Peer comparison

Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.

Metric ID: acquisitions

Historical Data

14 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q1 '26
Value$58.14M$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$37.92M
QoQ Change-100.0%
Range$0.00$58.14M
CAGR-12.3%

Frequently Asked Questions

What is KKR & Co.'s acquisitions?
KKR & Co. (KKR) reported acquisitions of $37.92M in Q1 2026.
What is the long-term trend for KKR & Co.'s acquisitions?
Over 2 years (2021 to 2024), KKR & Co.'s acquisitions has grown at a -100.0% compound annual growth rate (CAGR), from $473.78M to $0.00.
What does acquisitions mean?
Cash spent to acquire other companies or businesses, net of cash received in the deal.